Quality Control Technician

Overview

Replimune’s mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response, boldly transforming cancer care because

People are at the center of everything we do, and when it comes to our employees,

Replimune’s mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response, boldly transforming cancer care because

People are at the center of everything we do, and when it comes to our employees,
we make it personal. With a deep sense of purpose, a strong and evolving culture, a competitive and forward-looking total rewards program, everyone at Replimune has a unique opportunity to impact on the lives of patients, caregivers and themselves.

The Quality Control (QC) Technician will perform various laboratory- related activities such as reagent preparation, tissue culture, equipment maintenance, sample receipt and disposal, maintenance of consumable and reagent inventory, ordering reagents and preparing reagents following relevant standard operating procedure (SOP). After adequate experience and training the role can also involves performing some simple QC testing using established test methods

• Provide support to the day-to-day operation of the laboratories.
• Perform maintenance of laboratory equipment.
• Perform sample receipt and discard and maintain inventory.
• Order laboratory reagents and consumables as required.
• Prepare laboratory reagents and maintain various cell lines on regular basis by revival and passaging at set intervals.
• Perform data check and verification for documents.
• Perform general laboratory housekeeping tasks.
• Maintain reagent and consumable inventories.

• GCSE or equivalent in Mathematics, English and/or a science-based subject.

• A good time management skill and the ability to work in an organised manner.
• Good team player that is willing to adapt quickly
• Computer literacy (including MS Word and Excel),

Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response.

The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit

We are an Equal Opportunity Employer.